294 related articles for article (PubMed ID: 19564582)
1. Incidence and prevalence of CIDP and the association of diabetes mellitus.
Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
[TBL] [Abstract][Full Text] [Related]
2. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
[TBL] [Abstract][Full Text] [Related]
3. Demyelinating neuropathy in diabetes mellitus.
Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity between CIDP and diabetes mellitus: only a matter of chance?
Chiò A; Plano F; Calvo A; Leone M; Mutani R; Cocito D;
Eur J Neurol; 2009 Jun; 16(6):752-4. PubMed ID: 19475757
[TBL] [Abstract][Full Text] [Related]
5. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
Sun QL; Sun AP; Fu Y; Fan DS
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of chronic inflammatory demyelinating polyneuropathy.
Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
[TBL] [Abstract][Full Text] [Related]
7. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
8. Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.
Ng PS; Dyck PJ; Laughlin RS; Thapa P; Pinto MV; Dyck PJB
Neurology; 2019 Mar; 92(11):e1188-e1194. PubMed ID: 30760636
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
Kalita J; Misra UK; Yadav RK
Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal.
Rajabally YA; Peric S; Cobeljic M; Afzal S; Bozovic I; Palibrk A; Basta I
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1100-1104. PubMed ID: 32868389
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
[TBL] [Abstract][Full Text] [Related]
12. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands.
Broers MC; de Wilde M; Lingsma HF; van der Lei J; Verhamme KMC; Jacobs BC
J Peripher Nerv Syst; 2022 Sep; 27(3):182-188. PubMed ID: 35567759
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
Lotan I; Hellman MA; Steiner I
Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.
Vo ML; Hanineva A; Chin RL; Carey BT; Latov N; Langsdorf JA
Muscle Nerve; 2015 Apr; 51(4):549-53. PubMed ID: 25131219
[TBL] [Abstract][Full Text] [Related]
17. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.
Ramchandren S; Lewis RA
Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
19. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile.
Cea G; Idiáquez JF; Salinas R; Matamala JM; Villagra R; Stuardo A
J Clin Neurosci; 2020 Apr; 74():271-273. PubMed ID: 32067826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
